Icon

ASTELIN (nda020114)- (0.137MG/SPRAY)

AZELASTINE HYDROCHLORIDE NORVIUM BIOSCIENCE
0.137MG/SPRAY
Yes No
2011-Oct-16 Expired
None None
None No
Astelin Nasal Spray is an H1-receptor antagonist indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older and for the treatment of the symptoms of vasomotor rhinitis in adults and adolescent patients 12 years and older.
10 1 8
Total Other Developers None
Drugs with Suitability No
0.137MG/SPRAY ** ** - - 6
NDA Sales Available Total Generic Sales Available
No 8
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** *** ****** ***. *********** *** ****** *****, *******, ******* *** ***, ****** (***) ***
****** *** ***** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** ***** ****** ***** ************ ******* *********** ****** **. ***, *** & ***, ******* ***** ******** ******* ** * *, *******-*******, ***-******, ****. - *********, *********, ******* ******, ***** (***) ***
****** ***** ****-**** ******** ***. *********** **** ****** ****, ********, **** (**) *****, ****** ****** (***) ***
****** ****** ****** ***************, *** *********** *** ******** ***** ** **** *, **********, *** ****** (**) *****-****, ****** ****** (***) ***
****** ***** **** *** *&* ****** *** *** ***** ************ *********** **** ******* **, ******, ******** (**) *****-****, ****** ****** (***) ***
****** ***** **** *** ***** ************ ******* *********** **** **. ***/*, ***, ***/*, ***/* & ***/* ******* ****** ***** *****, *******, *****, ***** & *** ******, ***** (***) ***
****** ********* ****** *** *** ********** ******* *********** ****-**, **** **.**, *****, *.*.***, ******** *******, ********* ******, ******** ********, ********, ****** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.